Development
Predictmedix AI Inc.
PMED
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 3.50K | 2.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 3.50K | 2.60K |
| Cost of Revenue | -- | -- | -- | 0.00 | -- |
| Gross Profit | -- | -- | -- | 3.50K | 2.60K |
| SG&A Expenses | 290.20K | 462.60K | 309.30K | 586.20K | 301.80K |
| Depreciation & Amortization | 30.90K | 31.40K | 30.90K | 30.60K | 30.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 321.10K | 494.00K | 340.30K | 678.10K | 332.40K |
| Operating Income | -321.10K | -494.00K | -340.30K | -674.60K | -329.80K |
| Income Before Tax | -330.90K | -519.90K | -352.60K | -685.70K | -345.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -330.90K | -519.90K | -352.60K | -685.70K | -345.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -330.90K | -519.90K | -352.60K | -685.70K | -345.10K |
| EBIT | -321.10K | -494.00K | -340.30K | -674.60K | -329.80K |
| EBITDA | -313.60K | -486.40K | -332.80K | -667.60K | -322.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 147.85M | 140.23M | 133.04M | 122.01M | 116.48M |
| Average Diluted Shares Outstanding | 147.85M | 140.23M | 133.04M | 122.01M | 116.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |